This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Actress Elizabeth Perkins And Sanofi US Announce Nationwide Casting Call For Diabetes Co-Stars Documentary

Stocks in this article: SANSNY

BRIDGEWATER, N.J., Nov. 14, 2012 /PRNewswire/ -- Golden Globe and Emmy nominated actress Elizabeth Perkins, who is living with type 1 diabetes, is partnering with Sanofi US on the Diabetes Co-Stars awareness campaign to produce a new documentary that will feature people living with diabetes and those who support them. Beginning today through December 16, 2012 people can submit their stories to the nationwide casting call at www.DiabetesCoStars.com.

To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/57457-sanofi-us-elizabeth-perkins-casting-call-diabetes-co-stars-documentary

"I am partnering with Sanofi US to share my story through Diabetes Co-Stars and I look forward to hearing from others about their unique experiences living with diabetes and learning about the encouragement they receive from their own co-stars," said Perkins, star of the upcoming ABC sitcom "How to Live with Your Parents (For the Rest of Your Life)."

Perkins, who is one of nearly 26 million Americans living with diabetes, currently uses Lantus ® SoloSTAR ® (insulin glargine [rDNA origin] injection) as part of her overall diabetes treatment plan, which also includes exercise and a healthy diet. Another important aspect of Perkins' overall diabetes management is the support and encouragement from her husband, director and cinematographer Julio Macat.

"I always recommend to my patients that they reach out for support to help them manage their diabetes, as Elizabeth has done with her husband Julio," said Perkins' physician, Dr. David Kayne, M.D., of The Medical Group of Encino in Encino, Calif. "Elizabeth's story is the perfect example of how valuable a strong support system is in a person's overall diabetes treatment plan."

People living with diabetes are invited to nominate their co-star—the person in their life who has made the biggest impact on their personal diabetes journey. People can also nominate themselves if they support a family member or friend with diabetes. Submissions will be judged on their ability to inspire others through their story of support in diabetes management. To enter the casting call with a video or written entry, hear more about Perkins' story, and to view the official rules visit www.DiabetesCoStars.com. Two co-star teams of winners will be announced on January 31, 2013 along with more information about the documentary's premiere. Follow the Sanofi US Diabetes Facebook page and Twitter feed for additional updates.

Diabetes Co-Stars has helped millions of Americans understand the power of a strong support team for people living with diabetes since its launch in 2010. As part of this year's program, Sanofi US will sponsor the Diabetes Hands Foundation in support of their efforts to encourage an open dialogue around the realities of living with diabetes. The Diabetes Hands Foundation works to connect, engage, and empower people touched by diabetes.

Indications and Usage for Lantus (insulin glargine [rDNA origin] injection)

Prescription Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and children (6 years and older) with type 1 diabetes for the control of high blood sugar.  It should be taken once a day at the same time each day to lower blood glucose.

1 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,827.75 +12.81 0.07%
S&P 500 2,072.83 +5.80 0.28%
NASDAQ 4,787.3170 +29.0650 0.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs